Amarna Therapeutics
Leiden, Netherlands · Biopharma, Biotechnology, Health Care
Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of rare and prevalent diseases. The company is pioneering the development of gene therapies based on simian virus 40 (SV40), a macaque polyoma virus to which humans are immunologically naïve. Amarna has created a proprietary production cell line (SuperVe
Key facts
- Headquarters
- Leiden, Netherlands
- Employees
- Unknown
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- http://www.amarnatherapeutics.com/
- Company page
Recent activity at Amarna Therapeutics
- : Amarna Therapeutics and NorthX Biologics Finalize Agreement to Advance Nimvec™ AM510 Gene Therapy for Type 1 Diabetes. (date Fundz recorded it)
- : Amarna Therapeutics Partners with NorthX Biologics to Advance Nimvec™ AM510 Gene Therapy Development (date Fundz recorded it)
- : Amarna Therapeutics Partners with NorthX Biologics to Advance Nimvec™ AM510 Gene Therapy Development (date Fundz recorded it)
- : Aurelia Caparrós Appointed as Chief Business Officer of Amarna Therapeutics
- : Amarna Therapeutics announces appointment of Dr Henk Streefkerk as new CEO
- : Amarna Therapeutics Secures Additional €5 ($5.7) Million To Advance Its Transformative Gene Therapy Platform Towards Clinical Trials
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Amarna Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2021 | Funding Round | $5.4M |
Leadership
- Aurelia Caparrós, Chief Business Officer
- Henk Streefkerk, Chief Executive Officer
Verified email and direct lines for Amarna Therapeutics’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Companies similar to Amarna Therapeutics
- AnHeart Therapeutics · Biopharma, Biotechnology, Health Care, Manufacturing, Science And Engineering
- AbSci Corp · Biopharma, Biotechnology, Health Care, Manufacturing
- Drug Development Solutions (An LGC Business Unit) · Biotechnology, Health Care, Manufacturing, Science And Engineering
- Camp4 Therapeutics Corp · Biopharma, Biotechnology, Health Care, Science And Engineering
- PRISYM ID · Biotechnology, Health Care, Manufacturing, Science And Engineering
About Amarna Therapeutics: questions and answers
What does Amarna Therapeutics do?
Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of rare and prevalent diseases. The company is pioneering the development of gene therapies based on simian virus 40 (SV40), a macaque polyoma virus to which humans are immunologically naïve. Amarna has created a proprietary production cell line (SuperVe
Where is Amarna Therapeutics headquartered?
Amarna Therapeutics is headquartered in Leiden, Netherlands.
Has Amarna Therapeutics raised funding?
Yes. Fundz has recorded 1 funding event for Amarna Therapeutics. The most recent, Funding Round of $5.4M, was in Dec 2021.
Who leads Amarna Therapeutics?
Henk Streefkerk is a Chief Executive Officer at Amarna Therapeutics.
What is the latest news on Amarna Therapeutics?
On Jul 9, 2025, Amarna Therapeutics and NorthX Biologics Finalize Agreement to Advance Nimvec™ AM510 Gene Therapy for Type 1 Diabetes.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy